144 related articles for article (PubMed ID: 10966978)
1. Embryo implantation and GnRH antagonists: GnRH antagonists in ART: lower embryo implantation?
Kol S
Hum Reprod; 2000 Sep; 15(9):1881-2. PubMed ID: 10966978
[TBL] [Abstract][Full Text] [Related]
2. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
3. Gonadotrophin-releasing hormone antagonists for assisted conception.
Al-Inany H; Aboulghar M
Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
[TBL] [Abstract][Full Text] [Related]
4. High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.
Kol S; Lightman A; Hillensjo T; Devroey P; Fauser B; Tarlatzis B; Mannaerts B; Itskovitz-Eldor J
Hum Reprod; 1999 Sep; 14(9):2242-4. PubMed ID: 10469687
[TBL] [Abstract][Full Text] [Related]
5. Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor.
Mannaerts B; Gordon K
Hum Reprod; 2000 Sep; 15(9):1882-3. PubMed ID: 10966979
[TBL] [Abstract][Full Text] [Related]
6. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
7. In vitro fertilization stimulation protocol for normal responder patients.
Marci R; Caserta D; Lisi F; Graziano A; Soave I; Lo Monte G; Patella A; Moscarini M
Gynecol Endocrinol; 2013 Feb; 29(2):109-12. PubMed ID: 22943624
[TBL] [Abstract][Full Text] [Related]
8. The role of gonadotropin-releasing hormone antagonists in in vitro fertilization.
Diedrich K; Ludwig M; Felberbaum RE
Semin Reprod Med; 2001 Sep; 19(3):213-20. PubMed ID: 11679902
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of GnRH agonists and antagonists in an ovular donation program].
Saucedo de la Llata E; Moraga Sánchez MR; Batiza Reséndiz V; Santos Haliscak R; Galache Vega P; Hernández Ayup S
Ginecol Obstet Mex; 2004 Feb; 72():53-6. PubMed ID: 15216901
[TBL] [Abstract][Full Text] [Related]
11. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists.
Hernandez ER
Hum Reprod; 2000 Jun; 15(6):1211-6. PubMed ID: 10831542
[TBL] [Abstract][Full Text] [Related]
12. GnRH antagonists followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles.
Lindheim SR; Morales AJ
Hum Reprod; 2003 Oct; 18(10):2048-51. PubMed ID: 14507819
[TBL] [Abstract][Full Text] [Related]
13. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.
European and Middle East Orgalutran Study Group
Hum Reprod; 2001 Apr; 16(4):644-51. PubMed ID: 11278211
[TBL] [Abstract][Full Text] [Related]
14. Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation.
Christin-Maitre S; Olivennes F; Dubourdieu S; Chabbert-Buffet N; Charbonnel B; Frydman R; Bouchard P
Clin Endocrinol (Oxf); 2000 Jun; 52(6):721-6. PubMed ID: 10848876
[TBL] [Abstract][Full Text] [Related]
15. [Optimizing ovarian stimulation for IVF using GnRH antagonists].
Kolibianakis EM
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S42-5. PubMed ID: 15643688
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients.
Escudero E; Bosch E; Crespo J; Simón C; Remohí J; Pellicer A
Fertil Steril; 2004 Mar; 81(3):562-6. PubMed ID: 15037403
[TBL] [Abstract][Full Text] [Related]
17. [Biological effects of GnRH antagonists].
Devaux A; Pouly JL; Bachelot A; Mourouvin Z; de Mouzon J
Gynecol Obstet Fertil; 2004 Sep; 32(9):741-7. PubMed ID: 15380756
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
19. The effect of premature luteinizing hormone increases among high ovarian responders undergoing a gonadotropin-releasing hormone antagonist ovarian stimulation protocol.
Geng Y; Lai Q; Xun Y; Jin L
Int J Gynaecol Obstet; 2018 Jul; 142(1):97-103. PubMed ID: 29542120
[TBL] [Abstract][Full Text] [Related]
20. Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles.
Acevedo B; Sanchez M; Gomez JL; Cuadros J; Ricciarelli E; Hernández ER
Fertil Steril; 2004 Aug; 82(2):343-7. PubMed ID: 15302282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
